Option Care Health, Inc. $OPCH Stake Cut by Assetmark Inc.

Assetmark Inc. lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 85.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,969 shares of the company’s stock after selling 22,721 shares during the quarter. Assetmark Inc.’s holdings in Option Care Health were worth $110,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Cornerstone Planning Group LLC boosted its holdings in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after purchasing an additional 1,067 shares during the period. McIlrath & Eck LLC acquired a new position in Option Care Health in the 2nd quarter valued at approximately $37,000. Hantz Financial Services Inc. lifted its position in Option Care Health by 987.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock worth $39,000 after buying an additional 1,284 shares in the last quarter. Elevation Point Wealth Partners LLC acquired a new stake in shares of Option Care Health during the 2nd quarter valued at $40,000. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Option Care Health by 528.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock valued at $46,000 after acquiring an additional 1,183 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Trading Up 1.1%

Option Care Health stock opened at $36.09 on Tuesday. The business’s 50-day simple moving average is $33.97 and its 200-day simple moving average is $30.47. Option Care Health, Inc. has a 52 week low of $24.24 and a 52 week high of $36.80. The firm has a market capitalization of $5.73 billion, a PE ratio of 28.64, a PEG ratio of 2.13 and a beta of 0.84. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on OPCH shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft raised their price target on Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a research note on Tuesday, December 9th. Barrington Research boosted their price target on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. Truist Financial set a $40.00 price objective on Option Care Health in a report on Tuesday, January 13th. Finally, TD Cowen reiterated a “hold” rating on shares of Option Care Health in a research note on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and a consensus price target of $37.58.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.